Catheter Ablation of Paroxysmal and Persistent Atrial Fibrillation in Patients with Secondary Atrial Septal Defect. Evaluation of the Results and Impact on the Quality of Life

DOI: https://doi.org/10.30702/ujcvs/23.31(04)/Pet061-8692
Keywords: cardiac arrhythmia, congenital cardiac anomalies, pulmonary vein isolation, treatment outcome

Abstract

Introduction. The presence of atrial fibrillation (AF) in patients with secondary atrial septal defect (ASD) has significant impact on their quality of life (QoL) and reduces life expectancy. Current guidelines recommend catheter ablation (CA) for patients with AF in case of medical treatment failure, however, its use in patients with AF and ASD is still poorly studied.

The aim. To study the efficacy and safety of CA and its impact on the QoL in patients with AF and secondary ASD.

Materials and methods. In 2003-2023, 1408 patients with secondary ASD were treated at the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine. Of these, 54 patients who had AF and underwent the CA procedure were included in group 1 of our study. There were 36 (66.7%) men and 18 (33.3%) women aged 24-76 years (mean age 61.4 ± 9.8 years). Four (9.3%) patients had persistent AF and 50 (90.7%) patients had paroxysmal AF. Fifty-six patients with paroxysmal or persistent AF and with the comparable age, duration of symptoms and associated pathology but without ASD were examined as group 2. The type and results of surgical interventions were analyzed according to surgical reports. The results of the treatment and QoL were assessed using the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire during the follow-up period 1, 2 and 3 months after the procedure.

Results. Pulmonary vein isolation was performed in all 54 (100%) patients of the group 1, as well as cavotricuspid isthmus ablation in 26 (48.2%) cases, cavotricuspid isthmus ablation and left atrial linear ablation in 2 (3.6%) cases. Type, length and complication of the procedure were comparable to those in the group 2. Fourty-four (81.5%) patients with ASD were free from AF 3 months after procedure, and their results did not differ from those obtained in the group 2 (p > 0.05). Average QoL indicators according to AFEQT significantly improved in both groups of patients who underwent CA. The differences in post-treatment QoL between patients of both groups were insignificant (p > 0.05).

Conclusions. CA was found to be safe and beneficial in patients with AF and secondary ASD. The rate of procedural complications and cure rate in patients with AF and secondary ASD (81.5%) were compatible to those in patients without ASD (80.5%). AF has negative effect on the main indicators of the patient’s life. In patients with secondary AF with ASD who underwent CA, a significant improvement in AF symptoms and QoL according to the AFEQT questionnaire (total score 56.1 ± 2.7 before the procedure vs. 78.7 ± 4.0 at follow-up) was noted.

References

  1. Nesheiwat Z, Goyal A, Jagtap M. Atrial Fibrillation. [Updated 2023 Apr 26; cited 2023 Sep 02]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526072/
  2. Gumprecht J, Domek M, Lip GYH, Shantsila A. Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management. J Hum Hypertens. 2019;33(12):824-836. https://doi.org/10.1038/s41371-019-0279-7
  3. Feghaly J, Zakka P, London B, MacRae CA, Refaat MM. Genetics of Atrial Fibrillation. J Am Heart Assoc. 2018 Oct 16;7(20):e009884. https://doi.org/10.1161/JAHA.118.009884
  4. Nakagawa K, Akagi T, Nagase S, Takaya Y, Kijima Y, Toh N, et al. Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect: a comparison with transcatheter closure alone. Europace. 2019;21(11):1663-1669. https://doi.org/10.1093/europace/euz207
  5. Griffiths JR, Nussinovitch U, Liang JJ, Sims R, Yoneda ZT, Bernstein HM, et al. Catheter Ablation for Atrial Fibrillation in Adult Congenital Heart Disease: An International Multicenter Registry Study. Circ Arrhythm Electrophysiol. 2022 Sep;15(9):e010954. https://doi.org/10.1161/CIRCEP.122.010954
  6. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/ SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace. 2018;20(1):157-208. https://doi.org/10.1093/europace/eux275
  7. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. https://doi.org/10.1093/eurheartj/ehaa612
  8. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth Prevalence of Congenital Heart Disease Worldwide: A Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2011;58(21):2241-2247. https://doi.org/10.1016/j.jacc.2011.08.025
  9. Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455-463. https://doi.org/10.1093/ije/dyz009
  10. Evertz R, Reinders M, Houck C, Ten Cate T, Duijnhouwer AL, Beukema R, et al. Atrial fibrillation in patients with an atrial septal defect in a single centre cohort during a long clinical follow-up: its association with closure and outcome of therapy. Open Heart. 2020 Aug;7(2):e001298. https://doi.org/10.1136/openhrt-2020-001298
  11. Silversides CK, Haberer K, Siu SC, Webb GD, Benson LN, McLaughlin PR, et al. Predictors of Atrial Arrhythmias After Device Closure of Secundum Type Atrial Septal Defects in Adults. Am J Cardiol. 2008;101(5):683-687. https://doi.org/10.1016/j.amjcard.2007.10.035
  12. Van De Bruaene A, Moons P, Belmans A, Post MC, Luermans JG, Delcroix M, et al. Predictive model for late atrial arrhythmia after closure of an atrial septal defect. Int J Cardiol. 2013;164(3):318-322. https://doi.org/10.1016/j.ijcard.2011.07.010
  13. Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, et al. Long-term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta-analysis. J Am Heart Assoc. 2013 Mar 18;2(2):e004549. https://doi.org/10.1161/JAHA.112.004549
  14. Nyboe C, Olsen MS, Nielsen-Kudsk JE, Hjortdal VE. Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure. Heart. 2015;101(9):706-711. https://doi.org/10.1136/heartjnl-2014-306552
  15. Karunanithi Z, Nyboe C, Hjortdal VE. Long-Term Risk of Atrial Fibrillation and Stroke in Patients With Atrial Septal Defect Diagnosed in Childhood. Am J Cardiol. 2017;119(3):461-465. https://doi.org/10.1016/j.amjcard.2016.10.015
  16. Oliver JM, Gallego P, González A, Benito F, Mesa JM, Sobrino JA. Predisposing conditions for atrial fibrillation in atrial septal defect with and without operative closure. Am J Cardiol. 2002;89(1):39-43. https://doi.org/10.1016/S0002-9149(01)02160-9
  17. Vecht JA, Saso S, Rao C, Dimopoulos K, Grapsa J, Terracciano CM, et al. Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis. Heart. 2010;96(22):1789-1797. https://doi.org/10.1136/hrt.2010.204933
  18. Nie JG, Dong JZ, Salim M, Li SN, Wu XY, Chen YW, et al. Catheter ablation of atrial fibrillation in patients with atrial septal defect: long-term follow-up results. J Interv Card Electrophysiol. 2015;42(1):43-49. https://doi.org/10.1007/s10840-014-9958-z
Published
2023-12-28
How to Cite
Petkanych, M. M. (2023). Catheter Ablation of Paroxysmal and Persistent Atrial Fibrillation in Patients with Secondary Atrial Septal Defect. Evaluation of the Results and Impact on the Quality of Life. Ukrainian Journal of Cardiovascular Surgery, 31(4), 86-92. https://doi.org/10.30702/ujcvs/23.31(04)/Pet061-8692
Issue
Ukrainian Journal of Cardiovascular Surgery Vol 31 No 4 2023
Section
HEART RHYTHM DISORDER